Last Price
1.13
Today's Change
-0.01 (0.87%)
Day's Change
1.10 - 1.15
Trading Volume
235,500
Overview
Market Cap
3 Million
Shares Outstanding
3 Million
Avg Volume
4,863,217
Avg Price (50 Days)
1.47
Avg Price (200 Days)
35.02
PE Ratio
-0.05
EPS
-24.16
Earnings Announcement
15-May-2024
Previous Close
1.14
Open
1.14
Day's Range
1.109 - 1.15
Year Range
0.85 - 200.0
Trading Volume
248,661
Price Change Highlight
1 Day Change
-0.88%
5 Day Change
1.80%
1 Month Change
-23.65%
3 Month Change
-2.59%
6 Month Change
-88.11%
Ytd Change
-63.90%
1 Year Change
-99.31%
3 Year Change
-99.99%
5 Year Change
-99.99%
10 Year Change
-99.99%
Max Change
-99.99%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Apps
Top Articles
1
CEO Morning Brief
US Federal Court Enforces SEC's Subpoena to Depose Elon Musk
2
CEO Morning Brief
3
4
CEO Morning Brief
US Core CPI Cools for First Time in Six Months in Relief for Fed
5
CEO Morning Brief
Dow Breaches 40,000 Mark as Rate-cut Hopes Fuel Fresh Record High
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
